PA
VRRM icon

PharVision Advisers’s Verra Mobility VRRM Stock Holding History

PharVision Advisers’s Portfolio VRRM Stock Details VRRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Buy
+10,456
New +$110K 0.84% 59
2026
Q1 		– Sell
-10,834
Closed -$243K – 641
2025
Q4 		$243K Buy
+10,834
New +$247K 0.12% 414
2025
Q3 		– Sell
-10,820
Closed -$275K – 803
2025
Q2 		$275K Sell
10,820
-1,812
-14% -$42.2K 0.39% 100
2025
Q1 		$284K Buy
+12,632
New +$304K 0.39% 100

Other funds holding VRRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

PharVision Advisers's VRRM Position: Q2 2026 in Review

PharVision Advisers opened a new position in Verra Mobility (VRRM) in Q2 2026: 10,456 shares worth $44.4K. The stake represents 0.84% of the portfolio and ranks #59 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in VRRM as recently as Q4 2025.

PharVision Advisers first reported a position in VRRM in Q1 2025 and has held it in 4 quarters since. The position peaked at $284K in Q1 2025. 315 funds tracked by Wall St. Rank hold VRRM as of Q2 2026.

  • PharVision Advisers held 10,456 shares of Verra Mobility worth $44.4K as of Q2 2026.
  • Verra Mobility was a new PharVision Advisers position in Q2 2026.
  • Verra Mobility made up 0.84% of PharVision Advisers's portfolio in Q2 2026, its #59 holding.
  • PharVision Advisers first reported a position in Verra Mobility in Q1 2025 and has held it in 4 quarters since.
  • PharVision Advisers's Verra Mobility position peaked at $284K in Q1 2025.
  • 315 funds tracked by Wall St. Rank held Verra Mobility as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.